Mechanisms contributing to angiotensin II regulation of body weight

American Journal of Physiology - Endocrinology and Metabolism

Volumn 274, Issue 5 37-5, 1998, Pages

  Cassis, Lisa A ^a   Marshall, Dana E ^a   Fettinger, Michael J ^a   Rosenbluth, Brady ^a   Lodder, Robert A ^a  

^a University of Kentucky   (United States)

Author keywords

Infrared imagery; Metabolism; Renin angiotensin system; Weight gain

Indexed keywords

ANGIOTENSIN; HYDRALAZINE; LEPTIN;

ADIPOSE TISSUE; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; FLUID INTAKE; FOOD INTAKE; MALE; MEAN ARTERIAL PRESSURE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

EID: 0031832527     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1998.274.5.e867     Document Type: Article

References (40)

1. Abraham, G., and G. Simon. Autopotentiation of pressor responses by subpressor angiotensin II in rats. Am. J. Hypertens. 7: 269-275, 1994.
2. Baker, K. M., G. W. Booz, and D. E. Dostal. Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Annu. Rev. Physiol. 68: 905-921, 1992.
3. Brink, M., J. Sellen, and P. Delafontaine. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor 1 in rats through a pressor-independent mechanism. J. Clin. Invest. 97: 2509-2516, 1996.
4. Campbell, D. J., A. M. Duncan, and A. Kladis. Measurements of angiotensin peptides. Hypertension 26: 843-845, 1995.
5. Campfield, L. A., F. J. Smith, Y. Guisez, R. Devos, and P. Burn. Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546-549, 1995.
6. Cassis, L., M. Fettinger, A. Roe, U. Shenoy, and G. Howard. Characterization and regulation of angiotensin II receptor in rat adipose tissue. In: Recent Advances in Cellular and Molecular Aspects of Angiotensin Receptors, edited by M. Raizada. New York: Plenum, 1996, p. 39-47.
7. Cassis, L. A., and L. P. Dwoskin. Presynaptic modulation of neurotransmitter release by endogenous angiotensin II in brown adipose tissue. J. Neural. Transm. Suppl. 34: 129-137, 1991.
8. Cassis, L. A., J. A. Saye, and M. J. Peach. Location and regulation of rat angiotensinogen messenger RNA. Hypertension 11: 591-596, 1988.
9. Chai, S. Y. Localization of components of the renin-angiotensin system and site of action of inhibitors. Azeneimittelforschung 43: 214-221, 1993.
10. Collins, S., C. M. Kuhn, A. E. Petro, A. G. Swick, B. A. Chrunyk, and R. S. Surwit. Role of leptin in fat regulation. Nature 380: 677, 1996.
11. Diz, D. I., P. G. Baer, and A. Nasjletti. Angiotensin II-induced hypertension in the rat: effects on the plasma concentrations, renal excretion, and tissue release of prostaglandins. J. Clin. Invest. 72: 466-477, 1983.
12. Dostal, D. E., K. N. Rothblum, M. I. Chernin, G. R. Cooper, and K. M. Baker. Intracardiac detection of angiotensinogen and renin: a localized renin-angiotensin system in neonatal rat heart. Am. J. Physiol. 263 (Cell Physiol. 32): C838-C850, 1992.
13. Dzau, V. J. A comparative study of the distributions of renin and angiotensin messenger ribonucleic acids in rat and mouse. Endocrinology 120: 2334-2338, 1987.
14. Dzau, V. J. Cell biology and genetics of angiotensin in cardiovascular disease. J. Hypertens. 12, Suppl. 4: S3-S10, 1994.
15. Griffin, S., W. Brown, F. MacPherson, J. McGrath, V. Wilson, N. Korsgaard, M. Mulvany, and A. Lever. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 17: 626-635, 1991.
16. Henegar, J. R., G. L. Brower, A. Kabour, and J. J. Janicki. Catecholamine response to chronic ANG II infusion and its role in myocyte and coronary vascular damage. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H1564-H1569, 1995.
17. Hiramatsu, K., T. Yamada, K. Ichidawa, T. Izumiyama, and H. Nagata. Changes in endocrine activities relative to obesity in patients with essential hypertension. J. Am. Geriatr. Soc. 29: 25-30, 1981.
18. Lachance, D., and R. Garcia. Atrial natriuretic factor release by angiotensin II in the conscious rat. Hypertension 11: 502-508, 1988.
19. Levy, J., P. Lutz, M. Fischbach, J. Lutz, and C. Demangeat. Renin-angiotensin-aldosterone system in obese children. Arch. Fr. Pediatr. 39: 807-810, 1982.
20. 3-Adrenergic-mediated suppression of leptin gene expression in rats. Am. J. Physiol. 272 (Endocrinol. Metab. 35): E1031-E1036, 1997.
21. Luft, F., C. Wilcox, R. Unger, R. Kuhn, G. Demmert, P. Rohmeiss, D. Ganten, and R. Sterzel. Angiotensin-induced hypertension in the rat. Sympathetic nerve activity and prostaglandins. Hypertension 14: 396-403, 1989.
22. Mann, J. F. E., A. K. Johnson, and D. Ganten. Plasma angiotensin II: dipsogenic levels and angiotensin-generating capacity of renin. Am. J. Physiol. 238 (Regulatory Integrative Comp. Physiol. 7): R372-R377, 1980.
23. Melargno, M., and G. Fink. Inhibition of the slow pressor effect of angiotensin II contributes to the antihypertensive effect of angiotensin converting enzyme inhibitors in renovascular hypertension. J. Pharmacol. Exp. Ther. 278: 297-303, 1996.
24. Mulrow, P. J. Adrenal renin: regulation and function. Front. Neuroendocrinol. 13: 47-60, 1992.
25. Peach, M. J. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol. Rev. 57: 313-370, 1977.
26. Pedersen, E. B., H. Danielsen, T. Jensen, M. Madsen, S. Sorensen, and O. Thomsen. Angiotensin II, aldosterone, and arginine vasopressin in plasma in congestive heart failure. Eur. J. Clin. Invest. 16: 56-60, 1986.
27. Pelleymounter, M. A., M. J. Cullen, M. B. Baker, D. Winters, T. Boone, and F. Collins. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543, 1995.
28. Phillips, M. I. Levels of angiotensin and molecular biology of the tissue renin-angiotensin systems. Regul. Pept. 43: 1-20, 1993.
29. Pittman, J., and P. Cohen. The pathogenesis of cardiac cachexia. N. Engl. J. Med. 271: 403-409, 1964.
30. Quirk, W. S., J. W. Wright, and J. W. Harding. Tachyphylaxis of dipsogenic activity to intracerebroventricular administration of angiotensins. Brain Res. 452: 73-78, 1988.
31. Seikaly, M. G., B. S. Arant, and F. D. Seney. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J. Clin. Invest. 86: 1352-1357, 1990.
32. Shenoy, U., and L. Cassis. Characterization of renin activity in brown adipose tissue. Am. J. Physiol. 272 (Cell Physiol. 41): C989-C999, 1997.
33. Shuran, M., and R. Nelson. Quantitation of energy expenditure by infrared thermography. Am. J. Clin. Nutr. 53: 1361-1367, 1991.
34. Simon, G., G. Abraham, and G. Cserep. Pressor and subpressor angiotensin II administration. Two experimental models of hypertension. Am. J. Hypertens. 8: 645-650, 1995.
35. Staroukine, M., J. Devriendt, P. Decoodt, and A. Verniory. Relationships bewteen plasma epinephrine, norepinephrine, dopamine and angiotensin II concentrations, renin activity, hemodynamic state and prognosis in acute heart failure. Acta Cardiol. 39: 131-138, 1984.
36. Wilson, K. M., and M. J. Fregly. Angiotensin II-induced hypothermia in rats. J. Appl. Physiol. 58: 534-543, 1985.
37. Wong, P., S. Hart, A. Zaspal, A. Chiu, R. Ardecky, R. Smith, and P. Timmermans. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). J. Pharmacol. Exp. Ther. 255: 584-592, 1990.
38. Yang, C., J. Chan, and S. Chan. Unsustained dipsogenic response to chronic central infusion of angiotensin-III in spontaneously hypertensive rats. Endocrinology 132: 405-409, 1993.
39. Zhang, Y., R. Proenca, J. Maffei, M. Barone, L. Leopold, and J. Friedman. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432, 1994.
40. Zimmerman, B., E. Syberte, and P. Wong. Interactions between sympathetic and renin-angiotensin system. Hypertension 2: 581-587, 1984.